S1 WORKSHOP: THEORIES OF DRUG CRAVING
S2 ISSUES IN HUMAN PHARMACOLOGICAL MRI
S3 THE APPLICATION OF fMRI IN RODENTS TO THE STUDY OF PSYCHOACTIVE DRUGS
S4 NEUROIMAGING IN ANIMAL MODELS OF PSYCHIATRIC DISORDERS
S5 MEASURING ENDOGENOUS NEUROTRANSMITTER RELEASE WITH PET: PITFALLS, RECENT ADVANCES AND FUTURE CHALLENGES
S6 EXPLORING THE ROLE OF AMPA RECEPTOR SUBUNITS IN ADDICTIVE PROCESSES USING MICE WITH TARGETED DELETIONS OF GLUR1 AND GLUR2 SUBUNITS
S7 LONG-LASTING CHANGES IN DOPAMINE AND GLUTAMATE TRANSMISSION AND DRUG TAKING
S8 GLUTAMATERGIC CONTROL OF CUE-INDUCED REINSTATEMENT OF ALCOHOL- AND COCAINE-SEEKING BEHAVIOUR
S9 PROTEINS REGULATING GLUTAMATE TRANSMISSION THAT MEDIATE COCAINE ADDICTION
S10 VASOPRESSINERGIC MECHANISMS IN COGNITION
S11 NEUROPEPTIDE Y IN ANXIETY AND ALCOHOLISM
S12 GALANIN; A NOVEL THERAPEUTIC TARGET FOR STRESS-RELATED DISORDERS?
S13 EMERGING NEW NEUROPEPTIDERGIC TARGETS IN DEPRESSION AND ANXIETY?
S14 IMPAIRMENTS OF CELLULAR PLASTICITY AND RESILIENCE IN SEVERE MOOD DISORDERS: THERAPEUTIC IMPLICATIONS
S15 DISRUPTING RECONSOLIDATION REDUCES THE EFFECTS OF DRUG-ASSOCIATED STIMULI ON DRUG SEEKING
S16 ENVIRONMENTAL MODULATION OF SUBJECTIVE DRUG EFFECTS
S17 ENRICHED ENVIRONMENTS AND DRUG ABUSE VULNERABILITY
S18 GENETIC CONTROL OVER CONTEXTUAL INFLUENCES ON CENTRAL AND BEHAVIOURAL EFFECTS OF AMPHETAMINE
S19 IS PREPULSE INHIBITION USEFUL FOR TESTING TREATMENTS OF COGNITIVE DEFICITS IN SCHIZOPHRENIA?
S20 GENE×ENVIRONMENT INTERACTIONS IN THE DEVELOPMENT OF SCHIZOPHRENIA-LIKE ABNORMALITIES IN INFORMATION PROCESSING
S21 NEONATAL DISCONNECTION OF THE HIPPOCAMPUS ALTERS PREFRONTAL CORTICAL FUNCTION: IMPLICATIONS FOR SCHIZOPHRENIA
S22 CONDITIONAL DISCRIMINATIONS, TASK SETTING AND PREFRONTAL FUNCTION IN ANIMAL MODELS OF SCHIZOPHRENIA
S23 ENDOCANNABINOID SYSTEM AND OPIOID ADDICTION: BIOCHEMICAL ASPECTS
S24 INTERACTION BETWEEN CANNABINOID SYSTEM AND PSYCHOSTIMULANTS: BEHAVIOURAL AND NEUROCHEMICAL ASPECTS
S25 INVOLVEMENT OF RIMONABANT IN DRUG ADDICTION AND OBESITY
S26 ENDOCANNABINOID SYSTEM AND ALCOHOL ADDICTION AND RELAPSE: PHARMACOLOGICAL STUDIES
S27 DOUBLE DISSOCIATION OF THE MECHANISMS MEDIATING THE INDUCTION OF RECONSOLIDATION FROM THOSE MEDIATING THE EXPRESSION OF A CONDITIONED RESPONSE
S28 NMDA RECEPTORS AND COGNITION: THE GLYCINE B CO-AGONIST SITE AS A TARGET FOR IMPROVING COGNITIVE PERFORMANCE IN SCHIZOPHRENIA?
S29 REGULATION OF COGNITIVE FUNCTION BY METABOTROPIC GLUTAMATE RECEPTORS
S30 TRANSLATIONAL APPROACHES TO EXTINCTION: FACILITATION OF EXTINCTION BY NMDA RECEPTOR AGONISTS
S31 BEHAVIORAL AND NEURAL ADAPTATIONS DURING WITHDRAWAL FROM A NON-NEUROTOXIC REGIMEN OF (+)-3,4-METHYLENEDIOXYMETHAMPHETAMINE [(+)-MDMA; ECSTASY],
S32 CHRONIC METHAMPHETAMINE EXPOSURE AND INDUCTION OF LIMBIC PLASTICITY: DEVELOPMENT OF PHARMACOTHEREPEUTIC STRATEGIES
S33 MDMA, METHAMPHETAMINE AND THEIR COMBINATION: COMPARISON OF LONG-TERM BEHAVIOURAL AND NEURAL EFFECTS IN RATS
S34 LONG-TERM CHANGES IN SEROTONERGIC FUNCTION FOLLOWING MDMA ADMINISTRATION TO ADOLESCENT RATS
S35 ROLE OF MICROGLIA AND CYTOKINES IN MDMA-INDUCED LONG-TERM NEUROTOXICITY
S36 NEUROANATOMICAL PARSING OF OPIOID REWARD ‘LIKING’ AND ‘WANTING’ IN ACCUMBENS SHELL
S37 INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN THE REGULATION OF FEEDING BEHAVIOUR AND BODY WEIGHT: PHARMACOLOGICAL EFFECTS OF RIMONABANT, A CB1 CANNABINOID RECEPTOR ANTAGONIST
S38 STRESS, GLUCOCORTICOIDS AND OBESITY
S39 CAN OUR UNDERSTANDING OF DRUG ADDICTION PROVIDE INSIGHTS TO OBESITY AND OVER-EATING?
S40 PREFRONTAL DOPAMINE TRANSMISSION IN SCHIZOPHRENIA: IS D1 RECEPTOR A RELEVANT BIOMARKER?
S41 HUMAN AND ANIMAL APPROACHES TO DISCOVER THE BASES OF NICOTINE REINFORCEMENT
S42 THE NEURAL CIRCUITRY OF REWARD AND AVERSION IN NICOTINE ADDICTION
S43 INVOLVEMENT OF SIGNAL TRANSDUCTION CASCADES IN NICOTINE REINFORCEMENT
S44 GABAERGIC AND GLUTAMATERGIC MECHANISMS OF NICOTINE DEPENDENCE
S45 THE CONTROL OF HUMAN SELECTIVE ATTENTION BY CUES ASSOCIATED WITH NICOTINE
S46 DOPAMINE FIBER DENSITY LEVELS IN THE STRIATUM FOLLOW THE CORTICO-STRIATAL FUNCTIONAL DOMAINS IN NORMAL AND DA-LESIONED ANIMALS
S47 VARIATION IN THE DYNAMIC PROBABILITY OF DOPAMINE RELEASE BETWEEN LIMBIC- VERSUS MOTOR-ASSOCIATED PRIMATE STRIATUM
S48 KEY DIFFERENCES FROM RODENTS IN THE ACUTE AND CHRONIC ACTION OF PSYCHOSTIMULANTS IN PRIMATE STRIATUM: LESSONS FOR ADDICTION
S49 IMAGING DOPAMINE ACTIVITY IN FUNCTIONAL SUBDIVISION OF THE STRIATUM WITH PET: CLINICAL IMPLICATIONS
S50TO BE ANNOUNCED
S51 SOCIAL STRESS: AGGRESSIVE, DEFEATED, SUBORDINATE? ANHEDONIA VERSUS ESCALATED COCAINE BINGEING
S52 NEURONAL AND HORMONAL MECHANISMS UNDERLYING EXCESSIVE ALCOHOL SELF-ADMINISTRATION IN SOCIALLY STRESSED MONKEYS
S53 STRESS AND RELAPSE TO DRUG-TAKING BEHAVIOR: AN UPDATE
S54 USE OF PRECLINICAL DRUG PROFILE IN CLINICAL SETTINGS FOR NOVEL COMPOUNDS IN DEPRESSION
S55 TO BE ANNOUNCED
S56 ARE CHRONIC MODELS OF DEPRESSION BETTER THAN ACUTE SCREENING TESTS?
S57 AN ANIMAL MODEL OF DEPRESSION: SEPARATING NATURE AND NURTURE
O1 PREVIOUS EXPERIENCE OF ETHANOL WITHDRAWAL REDUCES WITHDRAWAL-INDUCED ANXIETY AND ELEVATIONS IN PLASMA CORTICOSTERONE, BUT INCREASES WITHDRAWAL-INDUCED C-FOS EXPRESSION IN LIMBIC AREAS
O2 THE STRIATAL DELTAFOSB EXPRESSION AFTER 4-DAY COCAINE TREATMENT IN ALCOHOL-PREFERRING AA AND ALCOHOL-AVOIDING ANA RATS
O3 ALTERED BEHAVIOURAL EFFECTS OF ETHANOL AND INCREASED VOLUNTARY ETHANOL CONSUMPTION IN MICE LACKING CCK2 RECEPTORS
O4 CENTRAL AND PERIPHERAL EFFECTS OF ETHANOL AND ACETALDEHYDE ON MEASURES OF ANXIETY IN RATS
O5 EFFECTS OF SUBTHALAMIC NUCLEUS LESIONS ON MOTIVATION FOR ALCOHOL IN RATS
O6 THE INVOLVEMENT OF NK-1 RECEPTOR IN THE BEHAVIOURAL EFFECTS OF ETHANOL
O7 ETHANOL SELF-ADMINISTRATION IN RATS FOLLOWING DELAYED ACCESS IN A CONTEXT ASSOCIATED WITH ETHANOL: MOTIVATIONAL ASPECTS AND ASSOCIATION WITH RESPONSE TO MILD STRESS
O8 LONG-LASTING RELAPSE VULNERABILITY BY STIMULI PREDICTIVE OF ALCOHOL AVAILABILITY IS INDEPENDENT OF ITS REINFORCING VALUE
O9 PHENOTYPING OF THE SEROTONIN TRANSPORTER KNOCKOUT RAT
O10 SILENCING DOPAMINE D3-RECEPTOR IN THE NUCLEUS ACCUMBENS SHELL IN VIVO INDUCES CHANGES IN COCAINE-INDUCED HYPERLOCOMOTION
O11 ICER OVEREXPRESSION IN THE NUCLEUS ACCUMBENS INCREASES BEHAVIORAL RESPONSES TO AMPHETAMINE
O12 CHRONIC ANTIDEPRESSANT TREATMENT AND HIPPOCAMPAL NEURONAL PLASTICITY: DRUG LEVELS AND EFFECTS ON THE CYTOSKELETAL MICROTUBULAR SYSTEM
O13 ACTIONS OF NOVEL ANTIPSYCHOTIC AGENTS POSSESSING 5-HT1A RECEPTOR AGONIST PROPERTIES ON APOMORPHINE-INDUCED PPI DISRUPTION
O14 THE CANNABINOID CB1 RECEPTOR INVERSE AGONIST, RIMONABANT, MODIFIES BODY WEIGHT AND ADIPONECTIN mRNA BY MODULATING FOOD INTAKE
O15 NEURONAL KV7 CHANNELS: A NEW TARGET FOR ANXIOLYTICS
O16 THE COMBINED EFFECTS OF THE 5-HT2A ANTAGONIST, MDL100,907, AND THE SELECTIVE 5-HT6 RECEPTOR ANTAGONIST, RO4368554, IN RAT MODELS OF PSYCHOSIS AND COGNITION
A1 STRESS-INDUCED BEHAVIORAL AND COGNITIVE DISTURBANCES: PREVENTION BY PITUITRIN TREATMENT
A2 EFFECT OF SEROTONIN DEPLETION ON 5-HT2A RECEPTOR-MEDIATED LEARNING: EVIDENCE FOR CONSTITUTIVE ACTIVITY OF THE 5-HT2A RECEPTOR IN VIVO
A3 EFFECTS OF ETHANOL ON RE-CONSOLIDATION OF HUMAN MEMORY
A4 INTERACTION OF NMDA AND GROUP I METABOTROPIC GLUTAMATE RECEPTORS IN AVERSIVE LEARNING
A5 REDUCED ATTENTION AND INCREASED IMPULSIVITY IN MICE LACKING NPY-Y2 RECEPTORS
A6 THE EFFECTS OF ETHANOL ON MEMORY AND LEARNING IN P AND NP RATS
A7 INFRALIMBIC-LESIONED RATS SHOW NORMAL SUMMATION, BUT DISRUPTED RETARDATION, FOLLOWING ACQUISITION OF CONDITIONED INHIBITION
A8 CONTEXT-DEPENDENT ACTION OF NICOTINE ON LEARNING: OPPOSITE EFFECTS IN THE OBJECT RECOGNITION TASK IN MICE
A9 COGNITIVE AND MOOD EFFECTS OF CAFFEINE AND THEANINE ALONE AND IN COMBINATION
A10 A DOSE-RANGING STUDY OF THE COGNITIVE AND MOOD EFFECTS OF GUARANÁ
A11 EFFECTS OF INTRA-ACCUMBENS SHELL HALOPERIDOL AND AMPHETAMINE ON LATENT INHIBITION OF CONDITIONED TASTE AVERSION
A12 GABAA AGONIST INJECTION IN PRELIMBIC CORTEX, BUT NOT IN INFRALIMBIC CORTEX, IMPAIRS CONTEXTUAL CONTROL OF RESPONSE CONFLICT IN RATS
A13 REPEATED LOW-DOSE Δ9-THC ADMINISTRATION INDUCES DEFICITS IN A RODENT ATTENTIONAL SET SHIFTING TASK
A14 CHOLINERGIC MODULATION OF ANTISACCADE PERFORMANCE
A15 EFFECTS OF SOCIAL ISOLATION ON TWO TYPES OF IMPULSIVITY
A16 BETA-ADRENOCEPTOR MEDIATED INHIBITION OF LONG-TERM REWARD-RELATED MEMORY RECONSOLIDATION
A17 INVOLVEMENT OF DOPAMINE D2 RECEPTORS IN THE NUCLEUS ACCUMBENS CORE AND SHELL IN AMPHETAMINE-INDUCED BEHAVIOURAL DISINHIBITION
A18 NICOTINE REVERSES THE WORKING MEMORY DEFICIT OBSERVED IN MICE OVEREXPRESSING HUMAN CASPASE-3
A19 DEFICIT OF COGNITIVE FUNCTIONS IN PAX6/SMALL EYE MUTANT MICE
A20 EFFECT OF D-AMPHETAMINE ON INTERVAL MEMORY IN RATS WITH CEREBELLAR LESION, EVALUATED WITH A RETROSPECTIVE TIMING TASK
A21 ENHANCEMENT OF REVERSAL LEARNING IN THE MOUSE WATER MAZE BY LOW-DOSE CANNABINOID AGONIST
A22 A PILOT FIELD STUDY INTO THE EFFECTS OF ALCOHOL ON COGNITIVE PERFORMANCE
A23 MOBILE PHONES AS A MEANS OF ASSESSING MOOD AND COGNITIVE PERFORMANCE: A PILOT FIELD STUDY ASSESSING EFFECTS OF EATING BEHAVIOUR
A24 EFFECTS OF METHYLPHENIDATE AND MODAFINIL ON STOP-SIGNAL REACTION TIME PERFORMANCE IN THE RAT
A25 DISSOCIATION OF PRELIMBIC AND INFRALIMBIC CORTEX CONTRIBUTIONS TO RESPONSE INHIBITORY CONTROL AND CONTINGENCY DETECTION
A26 COGNITIVE EFFECTS OF STRESS IN ANDALUCIAN CHILDREN AGED 8–12 YEARS
A27 DIFFERENCES IN CLASSICAL FEAR CONDITIONING AND FEAR-POTENTIATED STARTLE BETWEEN THE ROMAN RAT STRAINS
A28 LESIONS OF THE FORNIX AFFECT TIMING BEHAVIOUR IN RATS
A29 SEROTONIN AND REVERSAL LEARNING: A PSYCHOLOGICAL AND NEUROCHEMICAL ANALYSIS
A30 THE EFFECT OF ALCOHOL ON DIFFERENT MODES OF DISINHIBITION
A31 5-HT2 MODULATION OF THE DISCRIMINATIVE PROPERTIES OF AMPHETAMINE
A32 ENVIRONMENTAL ENRICHMENT REVERSES BEHAVIORAL ALTERATIONS IN RATS PRENATALY EXPOSED TO VALPROIC ACID
A33 BEHAVIOURAL EFFECTS OF CANNABINOID RECEPTOR AGONISTS IN DEVELOPING RATS
A34 LONG-TERM BEHAVIOURAL EFFECTS OF MATERNAL DEPRIVATION AND A SINGLE EXPOSURE TO THE CANNABINOID AGONIST WIN 55,212-2 IN YOUNG RATS OF BOTH SEXES
A35 THE ROLE OF THE 5-HT1A RECEPTOR IN THE DEVELOPMENT OF ANXIETY DISORDERS
A36 NEUROCHEMICAL CONSEQUENCES OF JUVENILE STRESS AND CHRONIC METHYLPHENIDATE TREATMENT ON DOPAMINERGIC FUNCTION IN THE RODENT LIMBIC CORTEX
A37 STIMULUS EFFECTS OF DRUGS WITH COMPLEX SPECTRUM OF BEHAVIORAL ACTIVITY
A38 SSR240600 AND SAREDUTANT, NK-1 AND NK-2 RECEPTOR ANTAGONISTS, RESPECTIVELY, INCREASE SOCIAL INTERACTION IN RATS, IN A MODEL SENSITIVE TO ANXIOLYTIC DRUGS
A39 Y1 RECEPTORS REGULATE AGGRESSIVE AND ANXIOLYTIC-LIKE BEHAVIOURS BY MODULATING SEROTONIN PATHWAYS
A40 NEUROKININ1 RECEPTOR ANTAGONISTS EXERT ANXIOLYTIC PROPERTIES IN THE GERBIL SOCIAL INTERACTION TEST AND BLOCK THE ANXIOGENIC ACTION OF CITALOPRAM
A41 ANXIOGENIC-LIKE PROFILE OF CB1 RECEPTOR ANTAGONIST AM-251 IN THE ELEVATED PLUS-MAZE IS IMMUNE TO PRIOR TEST EXPERIENCE
A42 WEAK ANXIOLYTIC-LIKE PROFILE OF SB-205384, A SELECTIVE POSITIVE MODULATOR OF α3β2γ2 GABAA RECEPTORS
A43 ANXIETY-RELATED BEHAVIOR IN TRANSGENIC RATS WITH LOW BRAIN ANGIOTENSINOGEN
A44 ASSOCIATION BETWEEN PLASMA MAGNESIUM-ION CONCENTRATION AND ANXIETY IN INBRED MICE
A45 EVALUATION OF GABAA RECEPTOR SUBTYPES MEDIATING THE DISCRIMINATIVE STIMULUS EFFECTS OF BENZODIAZEPINES IN SQUIRREL MONKEYS
A46 NO TOLERANCE TO THE ANXIOLYTIC EFFECT OF CHLORDIAZEPOXIDE AND BRETAZENIL IN TWO MOUSE MODELS OF ANXIETY
A47 FLUNITRAZEPAM AND AGGRESSION IN MALE RATS
A48 THE EFFECTS OF NOVEL BENZODIAZEPINE-SITE LIGANDS ON PUNISHED RESPONDING IN SQUIRREL MONKEYS
A49 THE EFFECTS OF NOVEL BENZODIAZEPINE-SITE LIGANDS IN MIDAZOLAM-DISCRIMINATING SQUIRREL MONKEYS
A50 ONE-WAY AVOIDANCE LEARNING AND DIAZEPAM IN FEMALE ROMAN HIGH- AND ROMAN LOW-AVOIDANCE RATS
A51 THE α2 GABAA RECEPTOR SUBTYPE MEDIATES THE ANXIOLYTIC PROPERTIES OF DIAZEPAM IN THE CONDITIONED EMOTIONAL RESPONSE PARADIGM
A52 ANXIOLYTIC EFFECTS OF CBPHARM-001 ISOLATED FROM MAGNOLIA OBOVATA AND ITS POSSIBLE MOLECULAR MECHANISMS
A53 CHARACTERIZATION OF THE DISCRIMINATIVE STIMULUS EFFECTS OF 5.6 AND 10 mg/kg PREGNANOLONE IN DBA/2J AND C57BL/6J MICE
A54 NEUROPROTECTIVE EFFECT OF NOOGLUTYL IN RATS WITH EXPERIMENTALLY PRODUCED HEMORRHAGIC STROKE
A55 CHRONIC ORAL ADMINISTRATION OF CALCIUM AND IRON TO ACCELERATE BODY LEAD DETOXIFICATION AFTER CHRONIC LEAD EXPOSURE IN WISTAR RATS
A56 CONSTITUTIVE RET RECEPTOR TYROSINE KINASE ACTIVITY LEADS TO INCREASED CEREBRAL CONCENTRATION OF DOPAMINE AND TO ENHANCEMENT OF COCAINE-INDUCED LOCOMOTOR ACTIVITY IN TRANSGENIC MEN2B MICE
A57 PROGESTERONE AND ESTRADIOL PREVENT THE MOTOR DEFICITS INDUCED BY SEED CYCAD IN RATS
A58 ANTI-IMMOBILITY EFFECTS OF BETA-CARBOLINES IN THE MOUSE FORCED-SWIM TEST
A59 EVALUATION OF ANTIDEPRESSANT ACTIVITIES OF ROSE OIL AND GERANIUM OIL IN THE MOUSE FORCED-SWIM TEST
A60 SURINABANT, A NEW CB1 RECEPTOR ANTAGONIST, DISPLAYS EFFICACY IN ANIMAL MODELS OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER
A62 BEHAVIOURAL EFFECTS OF SELECTED ANTI-EPILEPTICS IN MICE DEFEATED ON SOCIAL INTERACTIONS
A63 EFFECTS OF DESIPRAMINE AND TRAMADOL IN A CHRONIC MILD STRESS MODEL IN MICE ARE ALTERED BY YOHIMBINE BUT NOT BY PINDOLOL
A64 THE α2 ANTAGONIST YOHIMBINE ACCELERATES THE EFFECTS OF THE SSRI FLUOXETINE ON SCHEDULE-INDUCED POLYDIPSIA
A65 SUB-CHRONIC JET-LAG DISTURBS CIRCADIAN ACTIVITY, WITHOUT AFFECTING FORCED-SWIM AND ELEVATED PLUS-MAZE BEHAVIOR
A66 EFFECTS OF THREE NEUROKININ ANTAGONISTS AT THE NK-1, NK-2 or NK-3 RECEPTOR ON THE DRL 72 s SCHEDULE IN RATS
A67 MOUSE MODEL OF ANHEDONIA WITH INTERNAL CONTROL FOR CHRONIC STRESS: EFFECTS OF PRE- AND POST-STRESS TREATMENT WITH ANTIDEPRESSANT CITALOPRAM
A68 DENSITY AND AFFINITY OF 5-HT TRANSPORTER IN A MOUSE MODEL OF DEPRESSION
A69 EVALUATION OF PRE-EXPOSURE AND DEVELOPMENT OF SWIMMING STRATEGY IN TWO MOUSE STRAINS IN THE FORCED-SWIM TEST
A70 THE NON-PEPTIDE NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST J-113397 INDUCES ANTIDEPRESSANT-LIKE EFFECTS IN MICE
A71 ANTIDEPRESSANT-LIKE EFFECT OF A MICROINJECTION OF ALLOPREGNANOLONE IN THE DORSAL HIPPOCAMPUS AND LATERAL SEPTAL NUCLEUS IN THE RAT: INVOLVEMENT OF GABAA RECEPTOR
A72 THE EFFECT OF ACUTE AND CHRONIC MONOAMINE REUPTAKE INHIBITORS IN THE MOUSE ZERO-MAZE
A73 NS2389, A TRIPLE MONOAMINE REUPTAKE INHIBITOR, SHOWS IN VIVO EFFICACY IN ACUTE MODELS OF ANTIDEPRESSANT EFFECT
A74 HIPPOCAMPAL NEUROGENESIS CONTRIBUTES TO THE EFFICACY OF IMIPRAMINE AND CRF1 ANTAGONIST (SSR125543A) FOLLOWING A CHRONIC UNPREDICTABLE STRESS PROCEDURE IN MICE
A75 STUDY OF A POLYMORPHISM IN BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) AND THE RESPONSE TO CHRONIC UNPREDICTABLE STRESS AND ANTIDEPRESSANT TREATMENT IN MICE
A76 DIFFERENTIAL REINFORCEMENT FOR LOW-RATE BEHAVIOR: AN ASSAY SENSITIVE TO ANTIDEPRESSANTS IN PRIMATES?
A76A THE α7nACh RECEPTOR AGONIST, SSR180711, DISPLAYS ANTIDEPRESSANT-LIKE EFFECTS IN RODENTS
A77 ANTIPSYCHOTIC AND ANTIDEPRESSIVE ACTIVITY OF THE ALPHA-3 SUBUNIT SELECTIVE BENZODIAZEPINE AGONIST ELB139 IN RATS
A78 SELECTIVE SEROTONIN REUPTAKE INHIBITION POTENTIATES THE SUPPRESSIVE EFFECTS OF ANTIPSYCHOTICS ON CONDITIONED AVOIDANCE RESPONDING IN RATS
A79 CLOZAPINE AND HALOPERIDOL HAVE DISSOCIABLE EFFECTS ON DEFICITS IN ATTENTION AND EXECUTIVE FUNCTION INDUCED BY BLOCKADE OF NMDA RECEPTORS IN THE MPFC OF RATS
A80 THE EFFECT OF THE COMBINATION OF RITANSERIN AND HALOPERIDOL ON MK-801-INDUCED BEHAVIOR
A81 THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC CLOZAPINE IN C57BL/6 MICE
A82 THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC DRUG CLOZAPINE IN RATS TRAINED TO DISCRIMINATE 1.25 mg/kg CLOZAPINE VERSUS 5.0 mg/kg CLOZAPINE VERSUS VEHICLE IN A THREE-CHOICE DRUG DISCRIMINATION TASK
A83 NOVEL ANTIPSYCHOTIC WITH DOPAMINE ANTAGONISM AND GABAERGIC ACTIVITY
A84 EFFECT OF 9-PIPERAZINE-1-ILPYRROLE[2,1-B][1-3]BENZOTHIAZEPIN (ST2472) ON D-AMPHETAMINE HYPERMOTILITY WITH RESPECT TO HALOPERIDOL, AND OLANZAPINE AFTER ORAL ADMINISTRATION IN RATS
A85 EARLY ADMINISTRATION OF L-NAME IN WISTAR RATS PRODUCES BEHAVIORAL DEFICITS THAT CAN BE ATTENUATED BY HALOPERIDOL AND CLOZAPINE
A86 THEOPHYLLINE INHIBITS TOLERANCE AND SENSITIZATION INDUCED BY MORPHINE: A CONDITIONED PLACE PREFERENCE PARADIGM STUDY IN FEMALE MICE
A87 MODIFICATION OF NALOXONE-INDUCED WITHDRAWAL SIGNS BY ASCORBIC ACID IN MORPHINE-DEPENDENT GUINEA-PIGS
A88 THE AMPA POTENTIATOR LY404187 ATTENUATES THE EFFECTS OF AN ACUTE ETHANOL CHALLENGE IN RATS
A89 CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION WITH POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS
A90 CONTRASTING EFFECTS OF BUPROPION, A CLINICALLY APPROVED SMOKING CESSATION AID, IN RODENT MODELS OF NICOTINE DEPENDENCE
A91 PRE-ADOLESCENT PPA EXPOSURE ALTERS COCAINE REWARD AND SENSITIZATION IN ADULTHOOD
A92 ASSESSMENT OF GABAB ANTAGONIST PRECIPITATED WITHDRAWAL DURING CHRONIC ADMINISTRATION OF GAMMA-BUTYROLACTONE (GBL)
A93 PRENATAL STRESS ENHANCES COCAINE-PRIMED REINSTATEMENT OF COCAINE-SEEKING IN MALE RATS
A94 ABSENCE OF DRUG SIGNALS PREVENTS THE INITIATION OF COCAINE SELF-ADMINISTRATION
A95 DHEA ATTENUATES COCAINE-SEEKING BEHAVIOR IN THE SELF-ADMINISTRATION MODEL IN RATS
A96 THE SEROTONERGIC SOURCE OF VARIANCE IN THE PSYCHOSTIMULANT PROPERTIES OF DIETHYLPROPION IN MARMOSETS (CALLITHRIX PENICILLATA)
A97 GROUP I mGLU RECEPTOR ANTAGONISTS, EMQMCM AND MTEP, ATTENUATE THE BEHAVIORAL SENSITIZATION TO MOTOR EFFECTS OF COCAINE IN RATS
A98 SELF-ADMINISTRATION OF HEROIN DURING CONDITIONED WITHDRAWAL ENHANCES SUBSEQUENT HEROIN-SEEKING BEHAVIOUR
A99 NEUROPEPTIDE FF (NPFF) AND MORPHINE-INDUCED SENSITIZATION AND DEPENDENCE IN MICE
A100 THE NOVEL GROUP II METABOTROPIC GLUTAMATE AGONIST, LY379268, ATTENUATES DISCRETE CUE-INDUCED REINSTATEMENT OF HEROIN SEEKING
A101 BEHAVIOURAL SENSITIZATION TO METHAMPHETAMINE STIMULATORY EFFECTS ON LOCOMOTION: COMPARATIVE STUDY IN MICE AND RATS
A102 EFFECTS OF CENTRALLY VERSUS PERIPHERALLY ADMINISTERED ETHANOL IN C57BL/6J AND CD1 MICE
A103 EFFECT OF MTEP ON COCAINE-INDUCED INCREASES IN BREAK POINT ON A PROGRESSIVE RATIO SCHEDULE IN RATS
A104 ANTI-AGGRESSIVE AND ANXIOGENIC EFFECTS OF MDMA IN AGGRESSIVE AND TIMID SINGLY HOUSED MICE
A105 GHB EFFECTS ON THE REINSTATEMENT OF COCAINE-INDUCED CONDITIONED PLACE PREFERENCE IN MICE
A106 LONG-LASTING CONSEQUENCES OF ADOLESCENT EXPOSURE TO MDMA ON MORPHINE-INDUCED REWARD IN ADULT MICE
A107 REPEATED AMPHETAMINE PRE-TREATMENT RENDERS ACTIONS INSENSITIVE TO OUTCOME DEVALUATION
A108 INDIVIDUAL DIFFERENCES IN NICOTINE-INDUCED HYPERACTIVITY AND NICOTINE-INDUCED AUGMENTATION OF DOPAMINE TRANSPORTER FUNCTION AND TRAFFICKING TO THE CELL SURFACE IN PREFRONTAL CORTEX IN RATS
A109 BEHAVIORAL EFFECTS IN ADULT RATS OF CHRONIC TREATMENT WITH THE CANNABINOID RECEPTOR AGONIST WIN 55,212-2 DURING DIFFERENT PHASES OF DEVELOPMENT
A-110 ROLE OF PHYSIOLOGICAL FACTORS IN NICOTINE PREFERENCE
A111 ROLE OF EMOTIONALITY IN NICOTINE CRAVING
A112 CROSS-REINSTATEMENT BY COCAINE AND AMPHETAMINE OF MORPHINE-INDUCED PLACE PREFERENCE IN MICE
A113 ENHANCED MORPHINE-INDUCED ETHANOL DRINKING IN ALCOHOL-PREFERRING AA RATS SENSITIZED TO MORPHINE
A114 EFFECT OF CHRONIC ORAL NICOTINE TREATMENT ON DOPAMINE AUTORECEPTOR SENSITIVITY
A115 EFFECTS OF MORPHINE AND COCAINE ON LOCOMOTOR ACTIVITY IN NICOTINE-WITHDRAWN MICE
A116 A KEY ROLE FOR HYPOCRETIN IN REGULATING BRAIN REWARD FUNCTION AND REINSTATEMENT FOR DRUG-SEEKING BEHAVIOR IN RATS
A117 BEHAVIOUR AND C-FOS RESPONSE IN AMYGDALA AND RELATED STRUCTURES AFTER REPEATED OPIATE WITHDRAWAL EXPERIENCES
A118 GABAB RECEPTOR AGONISTS AND MODULATOR DECREASE COCAINE REWARDING AND SEEKING BEHAVIORS IN RATS
A119 ACETALDEHYDE INACTIVATION BY D-PENICILLAMINE BLOCKS THE BEHAVIORAL STIMULATION AFTER CENTRAL ACETALDEHYDE AND ETHANOL ADMINISTRATION
A120 PRE- AND POSTNATAL MANIPULATIONS ALTER COCAINE SELF-ADMINISTRATION BEHAVIOR IN APOMORPHINE-SUSCEPTIBLE AND APOMORPHINE-UNSUSCEPTIBLE WISTAR RATS AT ADULT AGE
A121 EXAMINATION OF CROSS-SENSITIZATION TO COCAINE OR HEROIN FOLLOWING REPEATED EXPOSURE TO NICOTINE
A122 LEARNING, BUT NOT ANXIETY AND SPONTANEOUS BEHAVIOR, IS AFFECTED BY PRENATAL EXPOSURE TO METHAMPHETAMINE IN ADULT MALE RATS
A123 EFFECTS OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODIES WITH DIFFERENT AFFINITIES FOR (+)-METHAMPHETAMINE ON (+)-METHAMPHETAMINE DISCRIMINATION IN PIGEONS
A124 MDMA-INDUCED LONG-TERM 5-HT1A RECEPTOR MODIFICATION IN MICE RAPHE DORSAL NUCLEUS
A125 COMPARISON OF TWO SCHEDULES OF LOTTERY-BASED ABSTINENCE REINFORCEMENT IN POLYDRUG USERS IN METHADONE MAINTENANCE THERAPY
A126 ATTENUATION OF CUE-INDUCED COCAINE SEEKING BY GLUTAMATE RECEPTOR ANTAGONISM IN THE NUCLEUS ACCUMBENS CORE
A127 ALTERED RESPONSIVENESS TO ALCOHOL IN NUCLEUS ACCUMBENS AFTER PRE-EXPOSURE TO NICOTINE AND WIN 55,212-2
A128 EFFECT OF CHRONIC NICOTINE TREATMENT ON LOCALIZATION OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS IN SH-SY5Y AND SH-EP1-Hα7 CELLS
A129 GLUTAMATE AND ASPARTATE LEVELS IN THE NUCLEUS ACCUMBENS DURING COCAINE SELF-ADMINISTRATION
A130 STIMULUS CONTROL OF HUMAN SELECTIVE ATTENTION AND INSTRUMENTAL AVOIDANCE BEHAVIOUR DEPENDS UPON EXPLICIT CONTINGENCY KNOWLEDGE
A131 FOOTSHOCK STRESS-INDUCED ALCOHOL RELAPSE: COMPARISON BETWEEN GENETICALLY SELECTED ALCOHOL-PREFERRING RATS AND NONSELECTED WISTARS
A132 INTERACTIONS BETWEEN NICOTINE AND THE CANNABINOID RECEPTOR AGONIST CP 55,940 IN THE MODULATION OF ANXIETY-RELATED RESPONSES IN ADOLESCENT RATS OF BOTH SEXES
B1 GUT–BRAIN MEDIATED ANOREXIA: IS THERE A ROLE FOR PYY 3-36?
B2 EFFECT OF BRAIN ANGIOTENSIN ON BODY WEIGHT
B3 SYSTEMIC ADMINISTRATION OF MTII INDUCES HYPOPHAGIA VIA A DISRUPTION IN THE DEVELOPMENT OF SATIETY
B4 R0-4590334 (VER23779) IS A SELECTIVE 5-HT2C RECEPTOR AGONIST THAT INDUCES HYPOPHAGIA VIA AN ENHANCEMENT IN SATIETY AND ACTIVATES BRAIN REGIONS IMPLICATED IN FEEDING BEHAVIOUR
B5 EFFECTS OF NICOTINIC RECEPTOR AGONISTS ON LOCOMOTOR ACTIVITY AND APPETITIVE AND CONSUMMATORY COMPONENTS OF FEEDING
B6 EFFECT OF SR141716A IN FEEDING REGULATION AND ITS INTERACTION WITH OREXIN A
B7 CONCURRENT TASTE PREFERENCE AFTER INTRAGASTRIC NUTRIENTS: THE ROLE OF CAPSAICIN-SENSITIVE VAGAL FIBRES
B8 SELECTIVE INCREASE OF DARK-PHASE WATER INTAKE IN NPY-Y2 AND -Y4 RECEPTOR KNOCKOUT MICE
B9 A NOVEL, AUTOMATED METHOD OF MEASURING THE MOUSE BEHAVIOURAL SATIETY SEQUENCE
B10 EFFECT OF SELECTED ANTIDEPRESSANTS ON INFLAMMATORY PROCESSES ASSOCIATED WITH MODEL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) IN MICE
B11 EFFECTS OF GROUP I METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS IN RAT MODELS OF PARKINSON’S DISEASE AND L-DOPA-INDUCED DYSKINESIA
B12 METABOTROPIC GLUTAMATE RECEPTORS AS POTENTIAL TARGETS OF ANTIPARKINSONIAN THERAPY
B13 INTRAPALLIDAL INJECTIONS OF GROUP III METABOTROPIC GLUTAMATE RECEPTORS AGONIST REDUCE AKINETIC DEFICITS IN PARKINSONIAN RATS
B14 INTERACTION BETWEEN METABOTROPIC GLUTAMATE AND ADENOSINE A2A RECEPTOR ANTAGONISTS AS A POTENT ANTI-PARKINSONIAN TREATMENT
B15 AN ANIMAL MODEL FOR ASSESSING THE POTENTIAL ANTIPARKINSONIAN CHARACTERISTICS OF M4 MUSCARINIC ANTAGONISTS: EFFECTS OF THE PARTIALLY SELECTIVE M4 ANTAGONIST TROPICAMIDE
B16 CORTICOTROPIN FACTOR (CRF) OVEREXPRESSION MODULATES FEAR CONDITIONING IN MICE
B17 IN VITRO AND IN VIVO CHARACTERIZATION OF THE VASOPRESSIN RECEPTOR ANTAGONIST SSR149415
B18 TOWARDS A NEW ANIMAL MODEL FOR STRESS-RELATED DISORDERS
B19 FACETS OF DEPRESSION AS REPRESENTED BY PATTERNS OF CHALLENGE TEST RESPONSES
B20 ENVIRONMENTAL STIMULATION REDUCES THE DEVELOPMENT AND EXPRESSION OF BEHAVIORAL SENSITIZATION TO COCAINE
B21 INTERACTION BETWEEN OPIOID AND CANNABINOID SYSTEMS: LONG-TERM EFFECT OF ADOLESCENT CHRONIC TREATMENT WITH THE CANNABINOID AGONIST CP55,940 ON μ-OPIOID RECEPTOR FUNCTIONAL ACTIVITY IN ADULT MALE AND FEMALE RATS
B22 COCAINE SELF-ADMINISTRATION EFFECTS ON WATER-MAZE SPATIAL LEARNING
B23 ESCALATION OF DRUG INTAKE REDUCES THE INCENTIVE MOTIVATIONAL PROPERTIES OF COCAINE
B24 ACQUISITION AND EXPRESSION OF COCAINE-INDUCED CONDITIONED PLACE PREFERENCE IN RATS: KAPPA OPIOID RECEPTOR INVOLVEMENT
B25 DISCRIMINATIVE STIMULUS EFFECTS OF γ-HYDROXYBUTYRATE: ROLE OF TRAINING DOSE
B26 SENSITIVITY TO THE INCENTIVE PROPERTIES OF COCAINE DOES NOT PREDICT SUSCEPTIBILITY TO COCAINE-INDUCED REINSTATEMENT IN CONDITIONED PLACE PREFERENCE
B27 ADOLESCENT CANNABINOID PRE-EXPOSURE EFFECTS ON COCAINE SELF-ADMINISTRATION, FOOD REINFORCED BEHAVIOR AND CEREBRAL GLUCOSE METABOLISM IN ADULT RATS
B28 SPONTANEOUS WITHDRAWAL FROM CHRONIC MORPHINE TREATMENT : IDENTIFICATION OF DIFFERENTIALLY EXPRESSED TRANSCRIPTS IN RAT PERIPHERAL BLOOD MONONUCLEAR CELLS
B29 WITHDRAWAL OF CHRONIC ETHANOL CONSUMPTION PRODUCES CHANGES ON BEHAVIOURAL PERFORMANCE BUT NOT IN DENSITY OF α7 HIPPOCAMPAL NICOTINIC RECEPTORS
B30 MORPHINE-INDUCED CONDITIONED PLACE PREFERENCE IN HETEROZYGOUS GDNF KNOCKOUT MICE
B31 3,4-METHYLENEDIOXYMETHAPMHETAMINE (MDMA) AND 4-OH-DIMETHYLTRYPTAMINE (PSILOCIN) INTERACTION IN RATS: BEHAVIORAL STUDY ON PREPULSE INHIBITION OF ACOUSTIC STARTLE REACTION AND ON LOCOMOTION
B32 INTRAHIPPOCAMPAL ALLOPREGNANOLONE REVERSES THE AUDIOGENIC SEIZURES INDUCED BY ALCOHOL WITHDRAWAL IN VOLUNTARY AND CHRONIC ALCOHOL-DRINKING RATS
B33 SR 141716A AND SOME BEHAVIORAL EFFECTS OF CANNABINOID AGONISTS IN MICE: NON-CB1 RECEPTORS?
B34 ALCOHOL SELF-ADMINISTRATION AND RELAPSE MODELS IN THE RAT: METHODOLOGICAL AND PHARMACOLOGICAL VALIDATION
B35 REDUCTION OF QUASI-MORPHINE WITHDRAWAL SYNDROME IN ADENOSINE A2A RECEPTOR KNOCKOUT MICE
B36 SLEEP DEPRIVATION ABOLISHES THE LOCOMOTOR STIMULANT EFFECT OF ETHANOL IN MICE
B37 EFFECTS OF PARADOXICAL SLEEP DEPRIVATION ON THE RAPID-ONSET TYPE OF BEHAVIORAL SENSITIZATION TO AMPHETAMINE IN MICE
B38 THE EFFECT OF NICOTINE PRETREATMENT ON METHAMPHETAMINE SELF-ADMINISTRATION, METHAMPHETAMINE-SEEKING, AND LOCOMOTOR ACTIVITY IN RATS
B39 ANTAGONISM OF THE STIMULANT EFFECTS OF COCAINE BY THE DOPAMINE TRANSPORTER LIGAND, JHW007
B40 ENRICHED ENVIRONMENT INDUCES ADAPTATIVE CHANGES IN MOUSE STRIATUM AND MODULATES BEHAVIOURAL RESPONSE TO DRUGS
B41 5-HT RECEPTOR PROTEIN EXPRESSION AND COCAINE-SEEKING BEHAVIOUR IN RATS AFTER FORCED ABSTINENCE FROM COCAINE SELF-ADMINISTRATION
B42 VOLUNTARY DRUG ABSTINENCE IN RATS, EFFECT OF CONDITIONED STIMULI AND DRUG-TAKING HISTORY
B43 INFLUENCE OF THE ENVIRONMENTAL CONTEXT ON THE IMPACT OF DRUG-ASSOCIATED CONDITIONED REINFORCERS ON DRUG SEEKING
B44 PERSEVERANCE OF EXPLORATION IN NOVEL ENVIRONMENTS PREDICTS MORPHINE PLACE CONDITIONING IN RATS
B45 AMPHETAMINE-INDUCED C-FOS EXPRESSION IN FUNCTION OF LOCOMOTOR REACTIVITY TO NOVELTY AND ANXIETY IN OUTBRED RATS
B46 CLASSICAL CONDITIONING OF THE LOCOMOTOR SUPPRESSIVE EFFECTS OF ANTAGONIST-PRECIPITATED NICOTINE WITHDRAWAL
B47 ENHANCEMENT OF THE CONDITIONED REINFORCING PROPERTIES OF STIMULI BY NICOTINE IN RATS
B48 NEUROPHARMACOLOGICAL MECHANISMS OF THE RECONSOLIDATION OF CS-DRUG MEMORIES: EFFECTS ON COCAINE SEEKING
B49 BLOCKADE OF β-ADRENERGIC RECEPTORS IN THE BED NUCLEUS OF THE STRIA TERMINALIS PREVENTS AMPHETAMINE-INDUCED BEHAVIOURAL SENSITIZATION IN RATS: COMBINED BEHAVIOURAL AND NEUROANATOMICAL APPROACHES
B50 NEURAL CIRCUITS POTENTIALLY ENGAGED IN THE INDUCTION OF AMPHETAMINE BEHAVIOURAL SENSITIZATION: A NEUROANATOMICAL APPROACH
B51 REDUCED ACUTE RESPONSE TO ETHANOL AND NEUROPEPTIDE mRNAs IN RELEVANT BRAIN AREAS IN THE ALCOHOL-PREFERRING RHA RAT STRAIN
B52 FOOD-INDUCED BEHAVIOURAL SENSITIZATION
B53 CONTRIBUTION OF THE PREFRONTAL CORTEX TO THE PERSISTENCE AND REINSTATEMENT OF DRUG SEEKING MAINTAINED BY A COCAINE-PAIRED CONDITIONED REINFORCER
B54 THE ROLE OF THE α2 GABAA RECEPTOR SUBTYPE IN MEDIATING THE REWARDING PROPERTIES OF BENZODIAZEPINES
B55 THE LACK OF A2A ADENOSINE RECEPTORS DIMINISHES THE REINFORCING EFFICACY OF COCAINE
B56 ENVIRONMENTAL MODULATION OF HEROIN-INDUCED LOCOMOTORY ACTIVITY AND FOS EXPRESSION
B57 INVOLVEMENT OF KAPPA/DYNORPHYN OPIOID SYSTEM IN CANNABINOID SELF-ADMINISTRATION IN MICE
B58 A RELIABLE MODEL OF INTRAVENOUS MDMA SELF-ADMINISTRATION IN MICE
B59 AUGMENTED REINFORCER VALUE AND ACCELERATED HABIT FORMATION AFTER AMPHETAMINE SENSITIZATION
B60 INVOLVEMENT OF OPIOID RECEPTORS IN THE TOLERANCE TO NICOTINE ANTINOCICEPTIVE EFFECTS
B61 MDMA ATTENUATES THC WITHDRAWAL SYNDROME IN MICE
B62 DECREASED GAD65 AND GAD67 EXPRESSION IN THE STRIATUM OF FEMALE COCAINE-SENSITIZED RATS
B63 EXTRACELLULAR CRF LEVELS IN THE CENTRAL NUCLEUS OF THE AMYGDALA AND ANXIETY-LIKE BEHAVIOR DURING NICOTINE WITHDRAWAL
B64 ACQUISITION OF OPIOID REINFORCEMENT IS PARALLELED BY AN INCREASE IN ACETYLCHOLINE BUT NOT DOPAMINE OVERFLOW IN THE NUCLEUS ACCUMBENS CORE
B65 ALCOHOLIC RATS SHOW FUNCTIONAL SENSITIZATION TO THE LEARNING EFFECTS OF INTRA-SEPTAL NICOTINE
B66 DIFFERENTIAL NEUROCHEMICAL AND BEHAVIOURAL EFFECTS OF RESPONSE-CONTINGENT AND RESPONSE-NON-CONTINGENT COCAINE EXPOSURE: SHELL/CORE DOPAMINE RESPONSIVENESS AND SENSITIZATION
B67 INCREASE IN BASAL GAD67 mRNA EXPRESSION IN THE CENTRAL NUCLEUS OF THE AMYGDALA: A MARKER OF STRESS AND DRUG-INDUCED BEHAVIOURAL SENSITIZATION
B68 CHRONIC MILD STRESS INDUCES DEPRESSIVE BEHAVIORS IN ADULT BUT NOT YOUNG RATS: POTENTIAL ROLE FOR AMPA RECEPTORS
B69 METHYLPHENIDATE ADMINISTRATION TO ADOLESCENT RATS DETERMINES SHORT- AND LONG-TERM CHANGES ON REWARD-RELATED BEHAVIOR AND STRIATAL GENE EXPRESSION
B70 MAJOR ROLE FOR VASOPRESSIN IN A NEW MOUSE MODEL OF ANXIETY AND DEPRESSION
B71 A KEY ROLE FOR HYPOTHALAMIC AVP IN ANXIETY/DEPRESSION-RELATED BEHAVIOR AND SOCIAL RECOGNITION: AN ANTISENSE STUDY
B72 A MOUSE MODEL OF POST-TRAUMATIC STRESS DISORDER
B73 THE EFFECTS OF ACUTE TRYPTOPHAN DEPLETION ON AFFECTIVE BEHAVIOUR AND COGNITION IN MALE AND FEMALE WISTAR RATS
B74 THE EFFECTS OF ACUTE TRYPTOPHAN DEPLETION ON BDNF PROTEIN LEVELS IN BRAIN AND SERUM OF MALE AND FEMALE RATS
B75 EFFECT OF 5-HT3 RECEPTOR ANTAGONIST MDL 72222 ON BEHAVIORS INDUCED BY KETAMINE IN RATS AND MICE
B76 DIFFERENTIAL CHANGES IN STRESS-INDUCED HYPERTHERMIA, DEPRESSION-LIKE BEHAVIOUR AND DEFAECATION BY NPY-Y2 AND -Y4 RECEPTOR GENE KNOCKOUT
B77 CITALOPRAM COUNTERACTS DEPRESSIVE-LIKE SYMPTOMS EVOKED BY CHRONIC SOCIAL STRESS IN RATS
B78 EFFECTS OF 5-HT2C AGONISTS AND ANTAGONISTS IN MICE TRAINED TO DISCRIMINATE MK212
B79 SEX-SPECIFIC EFFECTS ON STARTLE POTENTATION FOLLOWING EARLY LIFE STRESS
B80 BEHAVIOURAL ADAPTATION TO CHRONIC SOCIAL STRESS: ROLE OF HIPPOCAMPAL N/OFQ PEPTIDE
B81 THE EFFECT OF DEXMEDETOMIDINE AND ATIPAMEZOLE ON DOMINANT BEHAVIOUR IN AGGRESSIVE AND SOCIABLE MICE
B82 REPEATED PSYCHOSOCIAL THREAT-ENHANCED AGGRESSIVENESS IN MALE NMRI MICE; A BEHAVIOURAL SUBSTRATE FOR THE INCREASE IN BDNF SEEN IN THE HIPPOCAMPUS?
B83 DEPRESSIVE-LIKE BEHAVIOURAL AND BIOCHEMICAL RESPONSES IN CB1 KNOCKOUT MICE
B84 ANXIETY-INDUCED HYPERALGESIA: BIOCHEMICAL AND BEHAVIORAL STUDIES
B85 COGNITIVE DEFICITS IN BACE1 KNOCKOUT BUT NOT BACE1 TRANSGENIC MICE
B86 ALTERED SENSITIVITY TO PSYCHOMOTOR STIMULANT DRUGS IN APP TRANSGENIC MICE AT 3 MONTHS AND 1YEAR OF AGE
B87 THE EFFECTS OF ANOREXIC DRUGS ON FREE-FED RATS RESPONDING A SECOND-ORDER FI-15(FR-10:S) SCHEDULE FOR HIGH-INCENTIVE FOODS
B88 EFFECTS OF PLANT HEXASE GLYCOSIDE GG17 ON BEHAVIORAL AND NEUROCHEMICAL ABNORMALITIES IN THE MPTP-INDUCED ANIMAL MODEL OF PARKINSON'S DISEASE
B89 EFFECTS OF THE A2A RECEPTOR ANTAGONIST KW-6002 ON VIGILANCE AND MOTOR PERFORMANCE IN AGED RATS AND ANIMAL MODELS FOR EARLY- TO LATE-STAGE PARKINSON'S DISEASE
B90 ERK PHOSPHORYLATION AND FOSB EXPRESSION ARE ASSOCIATED WITH THE DEVELOPMENT OF DYSKINESIA FOLLOWING L-DOPA TREATMENT OF HEMIPARKINSONIAN MICE
B91 MGLUR5 BUT NOT MGLUR1 INTERACT WITH NMDA RECEPTORS IN CONTROLLING LOCOMOTOR ACTIVITY AND PREPULSE INHIBITION
B92 CHRONIC PCP PRODUCES ATTENTIONAL AND INHIBITORY RESPONSE CONTROL DEFICITS IN C57BL/6N MICE
B93 EFFECT OF RISPERIDON AND HALOPERIDOL IN ACTIVE ALLOTHETIC PLACE AVOIDANCE (AAPA) IN AN ANIMAL MODEL OF SCHIZOPHRENIA
B94 MICROINFUSION OF DOPAMINERGIC D1-RECEPTOR AGONIST SKF-38393 INTO THE PREFRONTAL CORTEX ENHANCES DIFFICULT BICONDITIONAL DISCRIMINATION PERFORMANCE
B95 CLOZAPINE BUT NOT HALOPERIDOL BLOCKS THE COGNITIVE IMPAIRMENT AND CHANGES IN EMOTIONAL BEHAVIOUR CAUSED BY REPEATED PHENCYCLIDINE IN MICE
B96 THE EFFECTS OF PSYCHOTOMIMETICS ON PERFORMANCE IN A NOVEL RODENT N-BACK PROCEDURE
B97 EFFECTS OF A D2 AGONIST ON PREPULSE INHIBITION IN INBRED C3H/HEJ, SPRET/EIJ AND CAST/EIJ MICE
B98 NEONATAL BRAIN INFUSION OF QUINOLINIC ACID INDUCES SCHIZOPHRENIA-LIKE BEHAVIOUR IN ADULT RATS
B99 CANNABINOIDS PREVENT COCAINE-INDUCED PSYCHOMOTOR STIMULATION
B100 ENDOCANNABINOID MODULATORS DO NOT EXHIBIT REINFORCING PROPERTIES BUT RATHER REDUCE THE REWARDING EFFECTS OF COCAINE IN THE INTRACRANIAL SELF-STIMULATION PARADIGM
B101 DELETION OF MCHR1 GENE RESTORES ACUTE AND CHRONIC COCAINE RESPONSIVENESS IN COCAINE-HYPOSENSITIVE MICE
B102 ATTENUATED EXPRESSION OF MORPHINE-CONDITIONED PLACE PREFERENCE IN GLUR-A KNOCKOUT MICE
B103 NICOTINE SELF-ADMINISTRATION DIFFERENTIALLY REGULATES TONIC AND PHASIC FIRING OF VTA DA NEURONS
B104 DIFFERENTIAL INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN THE ESTABLISHMENT AND THE SHORT- AND LONG-TERM EXPRESSION OF NICOTINE-INDUCED CONDITIONED PLACE PREFERENCE IN RATS
B105 EFFECTS OF VENLAFAXINE AND DESIPRAMINE ON HEROIN-INDUCED CONDITIONED PLACE PREFERENCE IN THE RAT
B106 TOWARDS A RODENT MODEL OF THE IOWA GAMBLING TASK: FIRST RESULTS
B107 METHYLPHENIDATE-INDUCED SUPPRESSION OF SOCIAL PLAY BEHAVIOR: A BEHAVIORAL AND PHARMACOLOGICAL ANALYSIS IN RATS
B108 A SINGLE SUCROSE–MORPHINE PAIRING LEADS TO TOLERANCE TO SUCROSE IN MALE C57BL/6 MICE
B109 ANALGESIC EFFECTS OF MORPHINE AND LOPERAMIDE IN THE RAT FORMALIN TEST: INTERACTIONS WITH NMDA RECEPTOR ANTAGONISTS
B110 ULTRA-LOW-DOSE ANTAGONIST PREVENTS CANNABINOID-INDUCED TOLERANCE
B111 EVALUATION OF MULTIPLICATIVE OPIOID ANTAGONIST INTERACTIONS IN THE RAT WARM-WATER TAIL-WITHDRAWAL ASSAY
B112 THE STIMULATING EFFECTS OF ECSTASY IN THE GENITAL REFLEXES OF PARADOXICALLY SLEEP-DEPRIVED RATS
B113 PARADOXICAL SLEEP DEPRIVATION POTENTIATES ‘ECSTASY’ (MDMA)-INDUCED LOCOMOTOR STIMULATION
B114 EFFECTS OF SLEEP RECOVERY ON AMPHETAMINE-INDUCED BEHAVIORAL SENSITIZATION IN MICE
B115 EFFECTS OF PARADOXICAL SLEEP DEPRIVATION AND AMINOTRIAZOLE (A CATALASE INHIBITOR) ADMINISTRATION ON MEMORY AND OROFACIAL DYSKINESIA IN MICE
B116 BEHAVIORAL EVIDENCE OF D1 DOPAMINE RECEPTOR SUPERSENSITIVITY INDUCED BY PARADOXICAL SLEEP DEPRIVATION IN MICE
B117 PREVIOUS PARADOXICAL SLEEP DEPRIVATION POTENTIATES RESERPINE-INDUCED OROFACIAL DYSKINESIA IN MICE
B118 THE ROLE OF NITRIC OXIDE IN ERECTION AND EJACULATION OF PARADOXICAL SLEEP-DEPRIVED MALE RATS
B119 EFFECTS OF PARADOXICAL SLEEP DEPRIVATION ON GENITAL REFLEXES IN FIVE RAT STRAINS
B120 BEHAVIORAL EFFECTS OF SEROTONIN IN PLANARIA
B121 EFFECT OF ASCORBIC ACID ON APOMORPHINE-INDUCED LICKING BEHAVIOR IN RAT
B122 EFFECTS OF DIFFERENT HISTAMINE RECEPTOR AGONISTS AND ANTAGONISTS ON FORMALIN-INDUCED NOCICEPTION IN MICE
B123 DEXTROMETHORPHAN ATTENUATES APOMORPHINE-INDUCED PECKING BEHAVIOR IN THE CHICK
B124 SHIRPA ANALYSIS OF THE COLOBOMA MUTANT MOUSE
B125 EFFECTS OF BETA-CARBOLINES HARMANE, NORHARMANE AND HARMINE ON APOMORPHINE-INDUCED STEREOTYPED BEHAVIORS IN RAT
B126 EFFECTS OF BETA-CARBOLINES HARMANE, NORHARMANE AND HARMINE ON ACETIC ACID-INDUCED WRITHING BEHAVIOR IN MICE
B127 EFFECTS OF THE ALCOHOL CONTENT OF A BEVERAGE ON DRINKING RATE
B128 INTRAHIPPOCAMPAL ALLOPREGNANOLONE REVERSES THE NICOTINE-INDUCED SEIZURES IN NON-SELECTED WISTAR RATS
B129 NEUROTROPHIC FACTOR CONTENT IN HIPPOCAMPUS AND AMYGDALA CORRELATE WITH CONDITIONED AND UNCONDITIONED FEAR IN C57BL/6 MICE
B130 THE USE OF THE ELEVATED PLUS-MAZE TEST WITH OPAQUE OR TRANSPARENT WALLS IN THE DETECTION OF MOUSE STRAIN DIFFERENCES AND THE ANXIOLYTIC EFFECTS OF DIAZEPAM
B131 SIGMA-1 RECEPTOR AGONISTS SENSITIZE MICE TO CAPSAICIN-INDUCED MECHANICAL ALLODYNIA
B132 ANTIALLODYNIC EFFECT OF HALOPERIDOL AND HALOPERIDOL METABOLITES I AND II IN MICE